Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call shows strong leasing activity, particularly in tech and AI sectors, with significant expansions and new leases. Market strategies focus on optimizing high-performing submarkets and capitalizing on AI-driven growth. Financial health is robust with substantial liquidity, and the shareholder return plan is stable. While some uncertainties exist, such as specific economic details and future leasing activity, overall sentiment is positive with strong market positioning and growth potential in core markets.
FFO (Funds From Operations) $1.13 per diluted share, which includes approximately $0.11 per share of onetime items. This includes a $10.7 million lease termination fee contributing $0.05 per share to FFO, and $6.9 million or $0.06 per share related to bad debt reversals and net real estate tax refund benefit.
Cash Same-Property NOI Growth 450 basis points in Q2 2025, with 300 basis points contributed by onetime items on a cash basis.
Occupancy 80.8% at the end of Q2 2025, down from 81.4% in Q1 2025. The decline was due to the rightsizing and renewal by DermTech and the early vacate related to the 23andMe bankruptcy.
GAAP Re-Leasing Spreads Negative 11.2% in Q2 2025, largely impacted by a single large lease in San Francisco. Excluding this transaction, cash re-leasing spreads would have been approximately positive 1%.
Cash Re-Leasing Spreads Negative 15.2% in Q2 2025, largely impacted by a single large lease in San Francisco. Excluding this transaction, cash re-leasing spreads would have been approximately positive 1%.
Disposition Proceeds $480 million of gross proceeds from 4 transactions, including land and operating property sales.
Land Sales $41 million for the 26th Street land in Los Angeles and $40 million for 501 Santa Monica in Downtown Santa Monica.
4-Building Campus Sale $365 million for a 4-building campus in Silicon Valley, which is 89% leased today but expected to decline to 65% leased in 2026.
AI Tenant Leasing: Signed a 93,000 square foot lease with an AI tenant at 201 Third Street asset in SOMA, marking the second consecutive quarter of major leasing at this property.
Life Science Leasing: Advanced to active lease negotiations on multiple transactions totaling approximately 100,000 square feet at Kilroy Oyster Point, with anticipated lease execution during the third and fourth quarters.
San Francisco Market Recovery: Active tenant demand in San Francisco has nearly doubled since 2023, now totaling approximately 7 million square feet. Positive trends in public safety and downtown revitalization have increased tenant confidence.
San Diego Market Strength: Broad-based activity across all submarkets, including record-high lease rates in Del Mar Heights and accretive lease-ups in Little Italy and UTC.
Capital Recycling: Announced the disposition of an operating property in downtown Santa Monica and a 4-building campus in Silicon Valley, raising over $480 million in gross proceeds.
Land Monetization: Signed agreements to sell land parcels in San Diego and Los Angeles, aggregating total expected gross proceeds of $79 million.
Portfolio Rotation: Focused on selling lower growth assets and reinvesting in high-performing submarkets to optimize portfolio returns.
Flower Mart Project Redesign: Reimagining the Flower Mart project in San Francisco to include a broader mix of uses, aiming to maximize long-term value.
San Francisco Office Market Challenges: Despite a resurgence in tenant demand, the San Francisco office market faces challenges due to significant space givebacks by big tech companies and the need for downtown revitalization efforts to sustain momentum.
Leasing Challenges in Silicon Valley: The 4-building campus in Silicon Valley being sold has a high vacancy risk, with two buildings expected to be fully vacant by 2026, requiring significant capital investment in a market with rent pressures.
Development Risks at Flower Mart Project: The Flower Mart project in San Francisco requires significant redesign and reimagining to adapt to market conditions, with uncertainties around approval processes and timelines for modifications.
Occupancy Decline and Leasing Spreads: Occupancy declined to 80.8%, with further expected declines in Q3. Negative re-leasing spreads, particularly in San Francisco, highlight challenges in achieving favorable lease terms.
Capital Allocation and Asset Dispositions: The company is selling lower-growth assets requiring outsized reinvestment, but this strategy depends on favorable market conditions to realize expected proceeds and reinvest effectively.
Life Science Ecosystem Challenges: The Kilroy Oyster Point project faces a challenging life science ecosystem, requiring active lease negotiations and significant tenant engagement to secure commitments.
Debt and Capital Structure Risks: The company plans to use proceeds from asset sales for debt repayment and reinvestment, but this strategy is contingent on market conditions and successful execution of dispositions.
Revenue and FFO Guidance: The company raised its 2025 FFO outlook to a range of $4.05 to $4.15 per share, reflecting a $0.15 increase at the midpoint. This includes updates for Flower Mart capitalization assumptions, termination fees, and same-property NOI guidance.
Occupancy Projections: Occupancy is expected to decline modestly in Q3 2025 due to redevelopment projects entering the stabilized portfolio but is anticipated to see positive net absorption in Q4 2025. The spread between leased and occupied space increased to 270 basis points, indicating built-in growth for late 2025 and 2026.
Same-Property NOI Growth: Same-property NOI growth is now expected to range from negative 1% to negative 2%, reflecting a 75-basis-point improvement at the midpoint. A deceleration is expected in the second half of 2025 due to one-time items and difficult year-over-year comparisons.
Capital Recycling and Dispositions: The company plans to recycle capital through the sale of non-core assets, including a 4-building campus in Silicon Valley and land parcels in Los Angeles and San Diego, generating over $480 million in gross proceeds. Proceeds will be used for reinvestment opportunities and debt repayment.
Development Pipeline: The Flower Mart project in San Francisco is undergoing redesign to include a broader mix of uses. Capitalization of interest and other expenses for the project is expected to cease at the end of 2025, with no capitalization assumed for 2026.
Market Trends and Leasing Activity: The company is optimistic about improving market conditions, particularly in San Francisco and San Diego. Leasing activity is expected to benefit from increased tenant demand, especially from AI and life science sectors.
leverage-neutral stock buybacks: The company is evaluating reinvestment options, including leverage-neutral stock buybacks, as part of its capital allocation strategy.
The earnings call reveals a positive outlook with raised FFO guidance and strong leasing activity, particularly in AI and life sciences. Despite challenges like declining NOI growth and lease terminations, the company's strategic focus on high-demand sectors and successful capital recycling provides a positive sentiment. The Q&A highlights management's proactive strategies in competitive leasing, especially in San Francisco, and the positive impact of acquisitions. The market cap indicates moderate sensitivity, suggesting a positive stock price movement of 2% to 8%.
The earnings call shows strong leasing activity, particularly in tech and AI sectors, with significant expansions and new leases. Market strategies focus on optimizing high-performing submarkets and capitalizing on AI-driven growth. Financial health is robust with substantial liquidity, and the shareholder return plan is stable. While some uncertainties exist, such as specific economic details and future leasing activity, overall sentiment is positive with strong market positioning and growth potential in core markets.
The earnings call highlights several negative indicators: a decline in occupancy and releasing spreads, significant interest income drop, and cautious growth outlook. While there is some positive news, such as land sales and tour activity improvements, these are overshadowed by negative financial metrics and uncertain market dynamics. The Q&A section reveals management's uncertainty about key projects, further contributing to a negative sentiment. Given the company's market cap, the stock price is likely to react negatively, falling in the -2% to -8% range over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.